Cell Source, Inc. (CLCS)
OTCMKTS · Delayed Price · Currency is USD
0.8500
0.00 (0.00%)
Feb 12, 2026, 9:30 AM EST

Cell Source Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023FY 2022FY 2021FY 2020FY 2019
Period Ending
Feb '26 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
411830436429
Market Cap Growth
219.80%-40.09%-30.67%-32.39%119.45%50.64%
Enterprise Value
522837506831
Last Close Price
0.850.460.851.282.001.10
PB Ratio
-2.19-1.15-2.37-4.40-8.04-5.07
Debt / Equity Ratio
-0.53-0.59-0.63-0.66-0.60-0.47
Net Debt / Equity Ratio
-0.53-0.59-0.61-0.65-0.57-0.46
Net Debt / FCF Ratio
-3.79-3.95-2.45-1.89-1.64-1.03
Quick Ratio
0.000.000.020.010.030.01
Current Ratio
0.010.010.030.030.050.02
Return on Assets (ROA)
-981.89%-864.18%-721.27%-655.68%-801.86%-2634.10%
Return on Capital Employed (ROCE)
21.30%26.80%33.00%40.90%45.80%68.00%
Earnings Yield
-15.83%-29.64%-17.25%-12.66%-7.13%-15.37%
FCF Yield
--13.08%-10.47%-7.82%-4.34%-8.88%
Buyback Yield / Dilution
-10.09%-8.47%-5.19%-13.81%-2.72%-2.83%
Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.